Differentiation of hepatic malignancies from hemangiomas and cysts by T2 relaxation times: Early experience with multiply refocused four-echo imaging at 1.5 T
Corresponding Author
Eric W. Olcott MD
Department of Radiology, Veterans Affairs Palo Alto Health Care System, Palo Alto, California 94304.
Department of Radiology, Stanford University School of Medicine, Palo Alto, California 94304.
Department of Radiology (114), Stanford University School of Medicine and Veterans Affairs Palo Alto Health Care System, 3801 Miranda Avenue, Palo Alto, California 94304.Search for more papers by this authorKing C.P. Li MD
Department of Radiology, Veterans Affairs Palo Alto Health Care System, Palo Alto, California 94304.
Department of Radiology, Stanford University School of Medicine, Palo Alto, California 94304.
Search for more papers by this authorGraham A. Wright PhD
Sunnybrook Health Science Centre, University of Toronto, Toronto, Ontario, Canada M5S1A1.
Search for more papers by this authorPhilip P. Pattarelli MD
Department of Radiology, Stanford University School of Medicine, Palo Alto, California 94304.
Search for more papers by this authorDouglas S. Katz MD
Department of Radiology, Stanford University School of Medicine, Palo Alto, California 94304.
Search for more papers by this authorIan Y. Ch'en MD
Department of Radiology, Stanford University School of Medicine, Palo Alto, California 94304.
Search for more papers by this authorBruce L. Daniel MD
Department of Radiology, Stanford University School of Medicine, Palo Alto, California 94304.
Search for more papers by this authorCorresponding Author
Eric W. Olcott MD
Department of Radiology, Veterans Affairs Palo Alto Health Care System, Palo Alto, California 94304.
Department of Radiology, Stanford University School of Medicine, Palo Alto, California 94304.
Department of Radiology (114), Stanford University School of Medicine and Veterans Affairs Palo Alto Health Care System, 3801 Miranda Avenue, Palo Alto, California 94304.Search for more papers by this authorKing C.P. Li MD
Department of Radiology, Veterans Affairs Palo Alto Health Care System, Palo Alto, California 94304.
Department of Radiology, Stanford University School of Medicine, Palo Alto, California 94304.
Search for more papers by this authorGraham A. Wright PhD
Sunnybrook Health Science Centre, University of Toronto, Toronto, Ontario, Canada M5S1A1.
Search for more papers by this authorPhilip P. Pattarelli MD
Department of Radiology, Stanford University School of Medicine, Palo Alto, California 94304.
Search for more papers by this authorDouglas S. Katz MD
Department of Radiology, Stanford University School of Medicine, Palo Alto, California 94304.
Search for more papers by this authorIan Y. Ch'en MD
Department of Radiology, Stanford University School of Medicine, Palo Alto, California 94304.
Search for more papers by this authorBruce L. Daniel MD
Department of Radiology, Stanford University School of Medicine, Palo Alto, California 94304.
Search for more papers by this authorAbstract
The purpose of this study was to examine hepatic lesions with a sequence designed to yield improved T2 measurements and evaluate the clinical utility of these measurements in distinguishing malignant from benign disease. Using a modified Carr-Purcell sequence incorporating features designed to compensate for imperfections in the imaging system, including a train of refocusing pulses emitted in an MLEV pattern oriented in composite fashion along all three coordinate axes, and a single spatially selective pulse placed immediately before a spiral readout, 14 benign lesions and 13 malignant lesions were evaluated prospectively with a conventional 1.5 T imager. The maximum, minimum, and mean T2 values of malignant lesions, hemangiomas, and cysts exceeded corresponding published values from spin-echo and echoplanar studies. The mean T2 value of the malignant lesions differed significantly (P < 0.0001) from those of hemangiomas and cysts. All malignant lesions and all benign lesions were distinguishable by their T2 values, which had ranges of no greater than 118.6 msec and no less than 134.3 msec, respectively. This early experience suggests that improved T2 measurements can facilitate the differentiation of hepatic malignancies from hemangiomas and cysts. J. Magn. Reson. Imaging 1999;9:81–86 © 1999 Wiley-Liss, Inc.
REFERENCES
- 1 McFarland EG, Mayo-Smith WW, Saini S, Hahn PF, Goldberg MA, Lee MJ. Hepatic hemangiomas and malignant tumors: improved differentiation with heavily T2-weighted conventional spin-echo MR imaging. Radiology 1994; 193: 43–47. Medline
- 2 Ohtomo K, Itai Y, Furui S, Yashiro N, Yoshikawa K, Iio M. Hepatic tumors: differentiation by transverse relaxation time (T2) of magnetic resonance imaging. Radiology 1985; 155: 421–423. Medline
- 3 Ohtomo K, Itai Y, Yoshikawa K, Kokubo T, Iio M. Hepatocellular carcinoma and cavernous hemangioma: differentiation with MR imaging; efficacy of T2 values at 0.35 and 1.5 T. Radiology 1988; 168: 621–623. Medline
- 4 Ohtomo K, Itai Y, Yoshida H, Kokubo T, Yoshikawa K, Iio M. MR differentiation of hepatocellular carcinoma from cavernous hemangioma: complementary roles of FLASH and T2 values. AJR 1989; 152: 505–507.
- 5 Reinig JW. Differentiation of hepatic lesions with MR imaging: the last word? Radiology 1991; 179: 601–602. Medline
- 6 Whitney WS, Herfkens RJ, Jeffrey RB, et al. Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T. Radiology 1993; 189: 863–870. Medline
- 7 Ebara M, Ohto M, Watanabe Y, et al. Diagnosis of small hepatocellular carcinoma: correlation of MR imaging and tumor histologic studies. Radiology 1986; 159: 371–377. Medline
- 8 Lombardo DM, Baker ME, Spritzer CE, Blinder R, Meyers W, Herfkens RJ. Hepatic hemangiomas vs metastases: MR differentiation at 1.5 T. AJR 1990; 155: 55–59.
- 9 Li KCP, Glazer GM, Quint LE, et al. Distinction of hepatic cavernous hemangioma from hepatic metastases with MR imaging. Radiology 1988; 169: 409–415. Medline
- 10 Ohtomo K, Itai Y, Matuoka Y, et al. Hepatocellular carcinoma: MR appearance mimicking cavernous hemangioma. J Comput Assist Tomogr 1990; 14: 650–652. Medline
- 11 Goldberg MA, Saini S, Hahn PF, Egglin TK, Mueller PR. Differentiation between hemangiomas and metastases of the liver with ultrafast MR imaging: preliminary results with T2 calculations. AJR 1991; 157: 727–730.
- 12 Goldberg MA, Hahn PF, Saini S, et al. Value of T1 and T2 relaxation times from echoplanar MR imaging in the characterization of focal hepatic lesions. AJR 1993; 160: 1011–1017.
- 13 Wright GA, Hu BS, Macovski A. Estimating oxygen saturation of blood in vivo with MR imaging at 1.5 T. J Magn Reson Imaging 1991; 1: 275–283. Medline
- 14 Li KCP, Wright GA, Pelc LR, et al. Oxygen saturation of blood in the superior mesenteric vein: in vivo verification of MR imaging measurements in a canine model. Radiology 1995; 194: 321–325. Medline
- 15 Foltz WD, Stainsby JA, Wright GA. T2 accuracy on a whole-body imager. Magn Reson Med 1997; 38: 759–768. Medline
- 16 Levitt MH, Freeman R. Compensation for pulse imperfections in NMR spin-echo experiments. J Magn Reson 1981; 43: 65–80.
- 17 Shaka AJ, Rucker SP, Pines A. Iterative Carr-Purcell trains. J Magn Reson 1988; 77: 606–611.
- 18 Wright GA, Nishimura DG, Macovski A. Flow-independent magnetic resonance projection angiography. Magn Reson Med 1991; 17: 126–140. Medline
- 19 MacFall M, Wehrli F, Breger R, Johnson G. Methodology for the measurement and analysis of relaxation times in proton imaging. Magn Reson Imaging 1987; 5: 209–220. Medline
- 20 Ishak KG, Rabin L. Benign tumors of the liver. Med Clin North Am 1975; 59: 995–1013. Medline
- 21 Villamil FG. Hepatic Tumors. In: G Gitnick, editor. Principles and practice of gastroenterology and hepatology. 2nd ed. Norwalk, CT: Appleton & Lange, 1994. p 977–1054.
- 22 Semelka RC, Brown ED, Ascher SM, et al. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced MR images. Radiology 1994; 192: 401–406. Medline
- 23 Hamm B, Thoeni RF, Gould RG, et al. Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. Radiology 1994; 190: 417–423. Medline
- 24 Ito K, Honjo K, Fujita T, et al. Liver neoplasms: diagnostic pitfalls in cross-sectional imaging. Radiographics 1996; 16: 273–293. Medline
- 25 Soyer P, Gueye C, Somvielle E, Laissy J-P, Scherrer A. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images. AJR 1995; 165: 1407–1413.
- 26 Mitchell DG, Saini S, Weinreb J, et al. Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging. Radiology 1994; 193: 49–57. Medline
- 27 Hamm B, Fischer E, Taupitz M. Differentiation of hepatic hemangiomas from metastases by dynamic contrast-enhanced MR imaging. J Comput Assist Tomogr 1990; 14: 205–216. Medline
- 28 Wittenberg J, Stark DD, Forman BH, et al. Differentiation of hepatic metastases from hepatic hemangiomas and cysts using MR imaging. AJR 1988; 151: 79–84.
- 29 Powers C, Ros PR, Stoupis C, Johnson WK, Segel KH. Primary liver neoplasms: MR imaging with pathologic correlation. Radiographics 1994; 14: 459–482. Medline
- 30 Choi BI, Han MC, Kim C-W. Small hepatocellular carcinoma versus small cavernous hemangioma: differentiation with MR imaging at 2.0 T. Radiology 1990; 176: 103–106. Medline
- 31 Mahfouz AE, Hamm B, Wolf KJ. Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology 1994; 190: 49–52. Medline
- 32 Rummeny E, Weissleder R, Stark DD, et al. Primary liver tumors: diagnosis by MR imaging. AJR 1989; 152: 63–72.
- 33 Itoh K, Saini S, Hahn PF, Imam N, Ferrucci JT. Differentiation between small hepatic hemangiomas and metastases on MR images: importance of size-specific quantitative criteria. AJR 1990; 155.
- 34 Egglin TK, Rummeny E, Stark DD, Wittenberg K, Saini S, Ferrucci JT. Hepatic tumors: quantitative tissue characterization with MR imaging. Radiology 1990; 176: 107–110. Medline
- 35 Stark DD, Felder RC, Wittenberg J, et al. Magnetic resonance imaging of cavernous hemangioma of the liver: tissue-specific characterization. AJR 1985; 145: 213–222.
- 36 Li W, Nissenbaum MA, Stehling MK, Goldman A, Edelman RR. Differentiation between hemangiomas and cysts of the liver with nonenhanced MR imaging: efficacy of T2 values at 1.5 T. J Magn Reson Imaging 1993; 3: 800–802. Medline
- 37 Tung GA, Vaccaro JP, Cronan JJ, Rigg JM. Cavernous hemangioma of the liver: pathologic correlation with high-field MR imaging. AJR 1994; 162: 1113–1117.